相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The long-term efficacy and safety of fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®) in diabetic macular oedema in a multi-ethnic inner-city population
Georgios D. Panos et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2021)
Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN® (0.19 mg fluocinolone acetonide implant)
Albert J. Augustin et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2020)
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment
Matus Rehak et al.
ACTA DIABETOLOGICA (2020)
The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema
Sara Vaz-Pereira et al.
OPHTHALMIC RESEARCH (2020)
The spatial relation of diabetic retinal neurodegeneration with diabetic retinopathy
Jacoba A. van de Kreeke et al.
PLOS ONE (2020)
Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
Usha Chakravarthy et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
The Role of Steroids in the Management of Diabetic Macular Edema
Dinah Zur et al.
OPHTHALMIC RESEARCH (2019)
First-line treatment algorithm and guidelines in center-involving diabetic macular edema
Laurent Kodjikian et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2019)
The USER Study: A Chart Review of Patients Receiving a 0.2μg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema
Alexander Eaton et al.
OPHTHALMOLOGY AND THERAPY (2019)
Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
Sidney A. Schechet et al.
BMJ OPEN OPHTHALMOLOGY (2019)
Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema
Joseph M. Coney
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2019)
Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients with Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience
James F. Young et al.
OPHTHALMOLOGY AND THERAPY (2019)
Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
Jessica D. McCluskey et al.
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2019)
Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
Joao Coelho et al.
CLINICAL OPHTHALMOLOGY (2019)
Fluocinolone Acetonide Intravitreal Implant 190 mu g (ILUVIEN (R)) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema
Bernardete Pessoa et al.
OPHTHALMIC RESEARCH (2018)
A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
Ye He et al.
BMC OPHTHALMOLOGY (2018)
Real-World Assessment of Dexamethasone Intravitreal Implant in DME: Findings of the Prospective, Multicenter REINFORCE Study
Michael A. Singer et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2018)
Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies
Laurent Kodjikian et al.
BIOMED RESEARCH INTERNATIONAL (2018)
The Pattern of Recurrence in Diabetic Macular Edema Treated by Dexamethasone Implant: The PREDIAMEX Study
David Bellocq et al.
OPHTHALMOLOGY RETINA (2018)
ILUVIEN® technology in the treatment of center-involving diabetic macular edema: a review of the literature
Maged S. Habib
THERAPEUTIC DELIVERY (2018)
Pharmacology of Corticosteroids for Diabetic Macular Edema
Scott M. Whitcup et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Iluvien (Fluocinolone Acetonide 0.19mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
William Fusi-Rubiano et al.
OPHTHALMOLOGY AND THERAPY (2018)
Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 μg/d intravitreal implant: real-world UK experience
Ibraheem El-Ghrably et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2017)
Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom
F. Alfaqawi et al.
EYE (2017)
Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy
A. Meireles et al.
EYE (2017)
Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom
C. Bailey et al.
EYE (2017)
A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN(R) in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsensive to Available Therapies (RESPOND)
Joao Figueira et al.
OPHTHALMIC RESEARCH (2017)
Evaluation of the clinical effectiveness in routine practice of fluocinolone acetonide 190 μg intravitreal implant in people with diabetic macular edema
Sarah E. Holden et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR. net Protocol T
Sophie Cai et al.
CURRENT OPINION IN OPHTHALMOLOGY (2017)
Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
Yahiya Y. Syed
DRUGS (2017)
Early and Long-Term Responses to Anti Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
Victor H. Gonzalez et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A. Wells et al.
OPHTHALMOLOGY (2016)
Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
Pedro Romero-Aroca et al.
JOURNAL OF DIABETES RESEARCH (2016)
Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIENA®) in Patients with Diabetic Macular Edema: 10 Eyes with 12 Months Follow-up
Ibrahim Elaraoud et al.
OPHTHALMOLOGY AND THERAPY (2016)
Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
Sobha Sivaprasad et al.
CLINICAL OPHTHALMOLOGY (2016)
Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
Pascale Massin et al.
CLINICAL OPHTHALMOLOGY (2016)
A review of therapies for diabetic macular oedema and rationale for combination therapy
W. M. K. Amoaku et al.
EYE (2015)
Correlation Between Ganglion Cell Layer Thinning and Poor Visual Function After Resolution of Diabetic Macular Edema
Sophie Bonnin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Ocular Pharmacokinetics of Fluocinolone Acetonide Following Iluvien Implantation in the Vitreous Humor of Rabbits
Frances E. Kane et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets
Arup Das et al.
OPHTHALMOLOGY (2015)
Intravitreal Aflibercept for Diabetic Macular Edema
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
Diabetic macular edema: new concepts in patho-physiology and treatment
Xinyuan Zhang et al.
CELL AND BIOSCIENCE (2014)
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Center-Involved Diabetic Macular Edema
Jennifer K. Sun et al.
JAMA OPHTHALMOLOGY (2014)
Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2013)
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials RISE and RIDE
David M. Brown et al.
OPHTHALMOLOGY (2013)
Structural Changes in Individual Retinal Layers in Diabetic Macular Edema
Tomoaki Murakami et al.
JOURNAL OF DIABETES RESEARCH (2013)
Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2012)
Five-year visual outcome following laser photocoagulation of diabetic macular oedema
S. Jyothi et al.
EYE (2011)
Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2011)
Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant
Joan-En Chang-Lin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Managing diabetic macular edema: The leading cause of diabetes blindness
Pedro Romero-Aroca
WORLD JOURNAL OF DIABETES (2011)
The Association Between Percent Disruption of the Photoreceptor Inner Segment-Outer Segment Junction and Visual Acuity in Diabetic Macular Edema
Anjali S. Maheshwary et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Role of Steroids in the Management of Diabetic Macular Edema and Proliferative Diabetic Retinopathy
Paolo S. Silva et al.
SEMINARS IN OPHTHALMOLOGY (2009)
Microglial activation in human diabetic retinopathy
Hui-yang Zeng et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin
DA Antonetti et al.
JOURNAL OF NEUROCHEMISTRY (2002)
分享论文
